📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events. (2023)

First Author: Farina N

Attributed to: MICA: Development of PEGylated Domain I of beta-2-glycoprotein I as a new therapeutic agent for the antiphospholipid syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/keac596

PubMed Identifier: 36227113

Publication URI: http://europepmc.org/abstract/MED/36227113

Type: Journal Article/Review

Volume: 62

Parent Publication: Rheumatology (Oxford, England)

Issue: 6

ISSN: 1462-0324